Amytrx Therapeutics, Inc.
1 clinical trials · Sponsor
◉ Watch Amytrx Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis (NCT04313400) | Amytrx Therapeutics, Inc. | 2020-03-10 |
Track Amytrx Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.